Leveraging adaptive clinical trial designs in oncology allows researchers to adjust predefined study elements based on accumulating data, such as dose levels, enrollment ratios, or stopping rules. These approaches embed learning directly into the study, improving efficiency and decision-making confidence.
In dose-finding oncology trials, adaptive methods support real-time assessment of pharmacokinetic (PK), pharmacodynamic (PD), safety, and efficacy data. This allows sponsors to make…
